| Year |
Citation |
Score |
| 2008 |
Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, Francis CW, Taubman MB, Phipps RP. Peroxisome proliferator-activated receptor γ and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles Thrombosis and Haemostasis. 99: 86-95. PMID 18217139 DOI: 10.1160/Th07-05-0328 |
0.519 |
|
| 2007 |
Brookes PS, Morse K, Ray D, Tompkins A, Young SM, Hilchey S, Salim S, Konopleva M, Andreeff M, Phipps R, Bernstein SH. The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore. Cancer Research. 67: 1793-802. PMID 17308122 DOI: 10.1158/0008-5472.Can-06-2678 |
0.519 |
|
| 2007 |
O'Brien JJ, Ray DM, Spinelli SL, Blumberg N, Taubman MB, Francis CW, Wittlin SD, Phipps RP. The platelet as a therapeutic target for treating vascular diseases and the role of eicosanoid and synthetic PPARγ ligands Prostaglandins and Other Lipid Mediators. 82: 68-76. PMID 17164134 DOI: 10.1016/J.Prostaglandins.2006.05.018 |
0.54 |
|
| 2006 |
Ray DM, Akbiyik F, Phipps RP. The peroxisome proliferator-activated receptor γ (PPARγ) ligands 15-deoxy-Δ12,14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARγ-independent mechanisms Journal of Immunology. 177: 5068-5076. PMID 17015690 DOI: 10.4049/Jimmunol.177.8.5068 |
0.57 |
|
| 2006 |
Feldon SE, O'Loughlin CW, Ray DM, Landskroner-Eiger S, Seweryniak KE, Phipps RP. Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes American Journal of Pathology. 169: 1183-1193. PMID 17003477 DOI: 10.2353/Ajpath.2006.060434 |
0.537 |
|
| 2006 |
Ray DM, Morse KM, Hilchey SP, Garcia TM, Felgar RE, Maggirwar SB, Phipps RP, Bernstein SH. The novel triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) induces apoptosis of human diffuse large B-cell lymphoma cells through a peroxisome proliferator-activated receptor gamma-independent pathway. Experimental Hematology. 34: 1202-11. PMID 16939813 DOI: 10.1016/J.Exphem.2006.04.026 |
0.578 |
|
| 2006 |
Baglole CJ, Ray DM, Bernstein SH, Feldon SE, Smith TJ, Sime PJ, Phipps RP. More than structural cells, fibroblasts create and orchestrate the tumor microenvironment Immunological Investigations. 35: 297-325. PMID 16916756 DOI: 10.1080/08820130600754960 |
0.524 |
|
| 2006 |
Ray DM, Spinelli SL, O'Brien JJ, Blumberg N, Phipps RP. Platelets as a novel target for PPARγ ligands: Implications for inflammation, diabetes, and cardiovascular disease Biodrugs. 20: 231-241. PMID 16831022 DOI: 10.2165/00063030-200620040-00004 |
0.565 |
|
| 2005 |
Ray DM, Akbiyik F, Bernstein SH, Phipps RP. CD40 engagement prevents peroxisome proliferator-activated receptor γ agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-κB-dependent mechanism Journal of Immunology. 174: 4060-4069. PMID 15778364 DOI: 10.4049/Jimmunol.174.7.4060 |
0.545 |
|
| 2005 |
Burgess HA, Daugherty LE, Thatcher TH, Lakatos HF, Ray DM, Redonnet M, Phipps RP, Sime PJ. PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. American Journal of Physiology. Lung Cellular and Molecular Physiology. 288: L1146-53. PMID 15734787 DOI: 10.1152/Ajplung.00383.2004 |
0.512 |
|
| 2005 |
Brookes P, Tompkins A, Morse K, Hilchey S, Salim S, Ray D, Phipps R, Bernstein SH. The Triterpenoids 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) and Their Imidazole (CDDO-Im) and Dinitrile Derivatives (DI-CDDO) Elicit Apoptosis through a Novel Mitochondrial Pathway. Blood. 106: 2426-2426. DOI: 10.1182/Blood.V106.11.2426.2426 |
0.534 |
|
| 2005 |
Ray D, Morse K, Hilchey S, Garcia T, Felgar R, Maggirwar S, Phipps R, Bernstein SH. The Novel Triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic Acid (CDDO) Induces Apoptosis of Human Diffuse Large B-Cell Lymphoma Cells (DLCL) through a Peroxisome Proliferator-Activated Receptor γ (PPARγ) Independent Pathway Which Is Enhanced by NFκB Inhibition. Blood. 106: 2425-2425. DOI: 10.1182/Blood.V106.11.2425.2425 |
0.576 |
|
| 2004 |
Ray DM, Bernstein SH, Phipps RP. Human multiple myeloma cells express peroxisome proliferator-activated receptor γ and undergo apoptosis upon exposure to PPARγ ligands Clinical Immunology. 113: 203-213. PMID 15451478 DOI: 10.1016/J.Clim.2004.06.011 |
0.573 |
|
| 2004 |
Akbiyik F, Ray DM, Bozkaya H, Demirpence E. Ligand- and species-dependent activation of PPARα Cellular Physiology and Biochemistry. 14: 269-276. PMID 15319530 DOI: 10.1159/000080336 |
0.398 |
|
| 2004 |
Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes Blood. 104: 1361-1368. PMID 15130939 DOI: 10.1182/Blood-2004-03-0926 |
0.562 |
|
| 2002 |
Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends in Immunology. 23: 144-50. PMID 11864843 DOI: 10.1016/S1471-4906(01)02154-8 |
0.6 |
|
| Show low-probability matches. |